Xenetic BiosciencesXBIO

13F holders, Q2 2026 (June 30)
8holders +2
2new positions
0sold out
1famous investor
$2.91avg. 13F price*

At the end of Q2 2026, 8 institutions reported holding Xenetic Biosciences Inc. (XBIO) in their 13F filings, up 2 from Q1 2026. 2 opened new positions and 0 sold out. The largest holders were Renaissance Technologies ($342K), Geode Capital Management, LLC ($51K) and Vanguard Capital Management LLC ($37K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Xenetic Biosciences Inc.
CUSIP
984015602
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q1 2024: 7Q1 2024Q2 2024: 5Q2 2024Q3 2024: 9Q3 2024Q4 2024: 13Q4 2024Q1 2025: 13Q1 2025Q2 2025: 9Q2 2025Q3 2025: 10Q3 2025Q4 2025: 11Q4 2025Q1 2026: 6Q1 2026Q2 2026: 8Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions2$3K
Exits0$0

All 13F filers, Q1 2026 → Q2 2026: 7,100 shares bought and 24,128 shares sold, net −17,028 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 8 holders

Renaissance Technologies 0.00% Reduce -14.6% 117,440 $342K
Geode Capital Management, LLC 0.00% Reduce -18.7% 17,423 $51K
Vanguard Capital Management LLC 0.00% Add +88.4% 12,681 $37K
JTC Employer Solutions Trustee Ltd 0.00% No change 2,700 $8K
SBI Securities Co., Ltd. 0.00% New 1,000 $3K
Tower Research Capital LLC (TRC) 0.00% Reduce -13.7% 696 $2K
Morgan Stanley 0.00% New 150 $437
Darwin Wealth Management, LLC 0.00% No change 2 $5

"% of holder's portfolio" is XBIO's weight in each manager's 13F, not the share of Xenetic Biosciences Inc. the manager owns.